UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
KIST to transfer immune-enhancing tech to EuBiologics
The Korea Institute of Science and Technology (KIST) said Monday it has sig...
by Constance Williams
|
2017-11-13 12:14
라인
Samsung Bioepis gets sales license for Samfenet
Samsung Bioepis said Thursday it has received domestic sales approval for S...
by Lee Han-soo
|
2017-11-09 16:03
라인
GemVax & KAEL place 1st in patent competition
GemVax & KAEL said Thursday it obtained first place in a competition for se...
by Marian Chu
|
2017-11-09 14:26
라인
Medipost’s CellTree emerges as nation’s leading cord blood bank
Korean celebrity couples, such as Ko So-young and Jang Dong-gun, Ki Sung-yu...
by Marian Chu
|
2017-11-09 11:32
라인
Toolgen registers ‘reporter gene’ patent for US genome editing
Toolgen툴젠 said Wednesday that it has registered a patent on “reporter genes...
by Constance Williams
|
2017-11-08 16:36
라인
Medipost gets Chinese patent for next-generation stem cell technology
MediPost has developed a next-generation culture method that can improve th...
by Constance Williams
|
2017-11-08 15:12
라인
World’s 1st gene therapy for osteoarthritis administered in Korea
Kolon Life Sciences said Wednesday it administered the first dose of its In...
by Marian Chu
|
2017-11-08 12:52
라인
ViroMed, Reyon in legal battle over gene therapy patent rights
The exclusive contract between ViroMed and Reyon Pharmaceutical to jointly ...
by Nam Doo-hyun
|
2017-11-07 14:10
라인
TissueGene shares trade low in Kosdaq debut
TissueGene, a U.S.-based biopharmaceutical affiliate of the Kolon Group, sa...
by So Jae-hyeon
|
2017-11-06 15:47
라인
Celltrion, Baxter BioPharma signs CMO accord for biosimilar production
Celltrion announced Friday that it has entered into a contract manufacturin...
by Constance Williams
|
2017-11-03 11:44
라인
Samsung BioLogics, Merck to extend strategic alliance
Samsung BioLogics said Thursday that it has signed a memorandum of understa...
by Lee Han-soo
|
2017-11-02 11:20
라인
Celltrion’s US sales of Remsima up 48% in Q3
Celltrion’s Remsima (ingredient: infliximab), a therapy to treat autoimmune...
by Nam Doo-hyun
|
2017-11-01 15:51
라인
Myongji, Macrogen agree on genome information-based disease management
Macrogen said Monday that it has signed a business agreement with Myongji M...
by Lee Han-soo
|
2017-10-31 17:06
라인
Celltrion unveils trial result for monoclonal antibody biosimilar
Celltrion said Tuesday that it has presented the results of phase 3 clinica...
by Lee Han-soo
|
2017-10-31 16:27
라인
Myongji Hospital chairman becomes MGmed’s largest shareholder
Lee Wang-jun, chairman of Myongji Hospital’s board of directors and chairma...
by Lee Hye-seon
|
2017-10-31 13:26
라인
Seoul, KHIDI opens ‘BioHub’ as control tower for bio-growth
The Seoul Metropolitan Government and the Korea Health Industry Development...
by Marian Chu
|
2017-10-30 16:35
라인
‘Government’s undue intervention hinders growth of CROs’
The government’s excessive intervention in the biopharmaceutical service ma...
by Nam Doo-hyun
|
2017-10-27 17:35
라인
Hugel Pharma launches 1st HA filler penis enlargement device
Hugel Biopharmaceuticals has obtained domestic sales license for the “Chaeu...
by Constance Williams
|
2017-10-27 17:29
라인
CTCBIO inks deal to export to Middle East, North Africa
Korean biotech company CTCBIO said Friday it had sealed a deal with two org...
by Marian Chu
|
2017-10-27 17:11
라인
IB, drug developer share know-hows on bio-industry startup
Synergy IB Partner, a corporate finance investment firm, and Korea Drug Dev...
by Lee Han-soo
|
2017-10-27 15:31
-
이전
21
22
23
24
25
26
27
28
29
30
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top